As of 2026-04-03, the Relative Valuation of Biogen Inc (BIIB) is 220.31 USD. This relative valuation is based on P/E multiples. With the latest stock price at 177.34 USD, the upside of Biogen Inc based on Relative Valuation is 24.2%.
The range of the Relative Valuation is 157.69 - 245.26 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 27.8x | 23.8x |
| Forward P/E multiples | 20.7x - 24.7x | 23.5x |
| Fair Price | 157.69 - 245.26 | 220.31 |
| Upside | -11.1% - 38.3% | 24.2% |
| Date | P/E |
| 2026-04-02 | 20.13 |
| 2026-04-01 | 20.86 |
| 2026-03-31 | 20.81 |
| 2026-03-30 | 21.29 |
| 2026-03-27 | 20.87 |
| 2026-03-26 | 21.69 |
| 2026-03-25 | 21.47 |
| 2026-03-24 | 20.88 |
| 2026-03-23 | 20.85 |
| 2026-03-20 | 20.60 |
| 2026-03-19 | 20.82 |
| 2026-03-18 | 20.69 |
| 2026-03-17 | 21.03 |
| 2026-03-16 | 20.80 |
| 2026-03-13 | 20.61 |
| 2026-03-12 | 20.99 |
| 2026-03-11 | 21.62 |
| 2026-03-10 | 21.39 |
| 2026-03-09 | 21.37 |
| 2026-03-06 | 20.99 |
| 2026-03-05 | 21.35 |
| 2026-03-04 | 21.56 |
| 2026-03-03 | 20.89 |
| 2026-03-02 | 21.35 |
| 2026-02-27 | 21.77 |
| 2026-02-26 | 21.34 |
| 2026-02-25 | 21.65 |
| 2026-02-24 | 22.15 |
| 2026-02-23 | 22.29 |
| 2026-02-20 | 21.80 |
| 2026-02-19 | 21.80 |
| 2026-02-18 | 22.04 |
| 2026-02-17 | 22.21 |
| 2026-02-13 | 22.31 |
| 2026-02-12 | 22.19 |
| 2026-02-11 | 21.70 |
| 2026-02-10 | 21.45 |
| 2026-02-09 | 22.00 |
| 2026-02-06 | 22.84 |
| 2026-02-05 | 21.04 |
| 2026-02-04 | 21.05 |
| 2026-02-03 | 20.06 |
| 2026-02-02 | 20.33 |
| 2026-01-30 | 20.42 |
| 2026-01-29 | 20.00 |
| 2026-01-28 | 19.85 |
| 2026-01-27 | 19.76 |
| 2026-01-26 | 19.65 |
| 2026-01-23 | 19.48 |
| 2026-01-22 | 19.73 |